Navigation Links
Perrigo Reports Record Sales and Earnings for Third Quarter Fiscal 2008
Date:5/6/2008

from $17.0 million in the year-ago period.

API

API segment third quarter net sales were $37.8 million, compared with $30.1 million last year, an increase of 26 percent. Operating income was $6.0 million, compared with $4.2 million last year. API performance in the quarter benefited from a one-time $4.9 million accrual reversal related to a long standing customer contract negotiation. For the first nine months of fiscal 2008, net sales were $111.2 million, up $22.7 million, or 26 percent from $88.5 million last year. Operating income was $16.7 million, compared with $14.9 million a year ago.

Other

The Other category, consisting of Israel Consumer Products and Israel Pharmaceutical and Diagnostic Products segments, reported third quarter net sales of $43.6 million, compared with $35.9 million a year ago, an increase of 22 percent. Operating income was $0.9 million, compared with $1.6 million last year. For the first nine months of fiscal 2008, net sales were $126.3 million, up $15.4 million, or 14 percent, compared with $110.9 million last year. Operating income was $6.9 million, compared with $7.0 million last year.

Unallocated Expenses

In the third quarter of fiscal 2008, unallocated expenses were $10.2 million, compared with $10.6 million a year ago. Both periods included an acquisition-related write-off of IPR&D. These pre-tax expenses were $2.8 million and $8.3 million, respectively. For the nine months in fiscal 2008, unallocated expenses were $15.7 million, compared with $18.7 million last year. Both periods included acquisition-related write-offs of IPR&D, which were $2.8 million and $8.3 million, respectively.

Outlook

The Company has refined its expected range of adjusted EPS for the full fiscal year to $1.55 to $1.60 per share, excluding acquisition and restructuring related charges. It has increased its full-year tax rate expectations to a range of 23 to 27 percent. The Company still expects to generat
'/>"/>

SOURCE Perrigo Company
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16

Related medicine news :

1. Perrigo Company Announces Quarterly Dividend
2. Perrigo Receives FDA Approval to Market Orange, Coated Nicotine Gum
3. Perrigo Company Will Release Third Quarter Fiscal 2008 Results on May 6, 2008
4. Perrigo Confirms Patent Challenge of Monistat(R) 1 Combination Pack
5. Perrigo Company to Present at the 12th Annual Sidoti Emerging Growth Institutional Investor Forum
6. Perrigo Company Announces Launch of Clobetasol Propionate Foam
7. Perrigo Company Receives Final Approval on Clobetasol Propionate Foam
8. Perrigo Company to Market Over-the-Counter Cetirizine Hydrochloride, Pseudoephedrine Hydrochloride Extended-Release Tablets
9. Perrigo Company Announces Initial Shipments of Store Brand Omeprazole Tablets
10. Perrigo Company Announces Final FDA Approval for OTC Famotidine Complete Chewable Tablets
11. Perrigo Company Authorizes Continuation of Share Repurchase Program and Announces Quarterly Dividend
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/23/2014)... evidence mounts showing the potential health benefits of probiotics, ... are taking supplements. And the chemical industry is getting ... health effects could deter growth, so the industry is ... according to the cover story in Chemical & ... the American Chemical Society. , Melody M. Bomgardner, a ...
(Date:4/23/2014)... a country as wealthy as the United States, it may ... not have access to adequate food due to lack of ... , Recent research at the University of Illinois using data ... that the seniors who are dealing with hunger are also ... 8.35 percent of Americans over age 60 faced the threat ...
(Date:4/23/2014)... team of scientists led by a researcher from the ... National University of Singapore has identified the cancer specific ... up the possibility of developing new drugs for the ... , The research group, led by Dr Chan Shing ... the first time that a cancer-specific variant of a ...
(Date:4/23/2014)... Physical Activity on Mobility Limitation in Old Age , ... of mobility limitation in old age, whereas leisure-time physical ... study which followed up 5,200 public sector employees for ... Research Center in Finland and the Finnish Institute of ... wears the body and lasts for several hours a ...
(Date:4/23/2014)... may prevent the depletion of self-control, according to research ... the Association for Psychological Science. , Self-control can be ... focus attention on a boring textbook are hard things ... this difficulty: Exerting self-control for a long period seems ... subsequent tasks. , "It is as if self-control is ...
Breaking Medicine News(10 mins):Health News:More Americans in their golden years are going hungry 2Health News:Scientists identify cancer specific cell for potential treatment of gastric cancer 2Health News:Scientists identify cancer specific cell for potential treatment of gastric cancer 3Health News:Midlife occupational and leisure-time physical activity limits mobility in old age 2Health News:ADHD drug may help preserve our self-control resources 2
... , The poll results come on the heels ... WASHINGTON, Aug. 7 A poll conducted by the American Red ... against the H1N1 virus, more than a third of parents (39%) have received ... (Logo: http://www.newscom.c o m/cgi-bin/prnh/20090108/RedCrossLOGO ...
... , WHEATON, Ill., Aug. 7 ... Hospital a grant in the amount of $15,000. The grant ... offers group classes for children with physical or developmental disabilities ... and improve their motor, sensory, play, communication and social skills, ...
... describes families as untapped resource in prevention efforts, , FRIDAY, ... child may be the victim of medical errors while in ... survey of 278 parents of children hospitalized in 2005 at ... watch over their child,s care to ensure there were no ...
... Emory University, believe conventional vaccine strategies should not be ... effective AIDS vaccine. Based on studying simian immunodeficiency viruses ... new approach to the AIDS vaccine research agenda in ... Nature Medicine . Their recommendations outline specific research priorities ...
... who excel at processing new information at 6- ... achievements as young adults in their 20,s, ... University Psychologist Joseph Fagan. Fagan,s "The prediction, from ... journal Intelligence , is receiving accolades. Mensa International, ...
... communication of the outcomes of medical tests whose results ... discharge is common and can lead to serious medical ... study by researchers from the Regenstrief Institute and the ... discharge summaries are grossly inadequate at documenting both tests ...
Cached Medicine News:Health News:Red Cross Poll Shows Parents Still Lack H1N1 Information From Schools 2Health News:DuPage Community Foundation Awards $15,000 Grant to Marianjoy Pediatric Continuing Care Program 2Health News:DuPage Community Foundation Awards $15,000 Grant to Marianjoy Pediatric Continuing Care Program 3Health News:When Kids Are Hospitalized, Parents Fret About Errors 2Health News:Yerkes researchers propose ambitious new strategies for AIDS vaccine research 2Health News:Yerkes researchers propose ambitious new strategies for AIDS vaccine research 3Health News:Ability to process information as a baby continues into adulthood 2Health News:Fumbled handoffs can lead to medical errors 2
(Date:1/15/2014)... 15, 2014 The Cadence Fitness & Health Center ... the Medical Fitness Association, a non-profit organization assisting medically ... potential. The Cadence Fitness & Health Center is the ... second in the Chicagoland area. "The certification ...
(Date:1/15/2014)... 15, 2014 Reportlinker.com announces that a ... its catalogue: PharmaPoint: ... Market Analysis to 2022 ... - India Drug Forecast and Market Analysis ...
(Date:1/15/2014)... YORK , Jan. 15, 2014 ... market research report is available in ... Global Markets and Technologies for Advanced ... Routes of Administration ...
Breaking Medicine Technology:Cadence Fitness & Health Center Certified as Medical Fitness Facility 2Cadence Fitness & Health Center Certified as Medical Fitness Facility 3PharmaPoint: Atopic Dermatitis - India Drug Forecast and Market Analysis to 2022 2PharmaPoint: Atopic Dermatitis - India Drug Forecast and Market Analysis to 2022 3PharmaPoint: Atopic Dermatitis - India Drug Forecast and Market Analysis to 2022 4PharmaPoint: Atopic Dermatitis - India Drug Forecast and Market Analysis to 2022 5Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 2Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 3Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 4Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 5Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 6Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 7Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 8Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 9Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 10Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 11Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 12Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 13Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 14Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 15Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 16
... THE OHIO STATE UNIVERSITY ... CENTER JOINS PHASE III TRIAL FOR METASTATIC MELANOMA ... (Nasdaq: DCTH ) announced today that The Ohio ... Research Institute has joined Delcath,s Phase III clinical trial for the treatment ...
... online this week in the Journal of Clinical ... selective estrogen receptor modulator (SERM) being developed by Eli ... increased lumbar spine and total hip bone mineral density ... mass, versus placebo.In addition, arzoxifene, dosed at 20 mg/day, ...
Cached Medicine Technology:Delcath Continues Expansion of Clinical Trial Centers Offering PHP(TM) 2Delcath Continues Expansion of Clinical Trial Centers Offering PHP(TM) 3Newly Published Phase III Study Shows Arzoxifene Significantly Increased Bone Mineral Density 2Newly Published Phase III Study Shows Arzoxifene Significantly Increased Bone Mineral Density 3Newly Published Phase III Study Shows Arzoxifene Significantly Increased Bone Mineral Density 4
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
Medicine Products: